Minimed Group (STU:B8S) Scaled Net Operating Assets: 0.80 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:B8S Minimed Group Inc STU:B8S
20 GF Score
Price €16.60
! 3 Warning Signs
View Full Analysis

What is Minimed Group Scaled Net Operating Assets?

Minimed Group STU:B8S 20 Scaled Net Operating Assets is 0.80 as of Apr. 2026. GuruFocus rates STU:B8S with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Minimed Group's operating assets for the quarter that ended in Apr. 2026 was €3,704 Mil. Minimed Group's operating liabilities for the quarter that ended in Apr. 2026 was €747 Mil. Minimed Group's Total Assets for the quarter that ended in Jan. 2026 was €3,696 Mil. Therefore, Minimed Group's scaled net operating assets (SNOA) for the quarter that ended in Apr. 2026 was 0.80.


Minimed Group Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Minimed Group's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minimed Group Scaled Net Operating Assets Chart

Minimed Group Annual Data
Trend Apr23 Apr24 Apr25 Apr26
Scaled Net Operating Assets
0.00 0.00 0.78 0.79

Minimed Group Quarterly Data
Apr24 Jan25 Apr25 Oct25 Jan26 Apr26
Scaled Net Operating Assets Get a 7-Day Free Trial 0.00 0.00 0.78 0.81 0.80

STU:B8S vs MMSI, NVST, STVN: Scaled Net Operating Assets Comparison

For the Medical Instruments & Supplies subindustry, Minimed Group's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Minimed Group Scaled Net Operating Assets vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Minimed Group's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Minimed Group's Scaled Net Operating Assets falls into.


STU:B8S
20GF Score
Minimed Group Inc STU:B8S
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Minimed Group Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Minimed Group's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Apr. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(A: Apr. 2026 )
=(Operating Assets (A: Apr. 2026 )-Operating Liabilities (A: Apr. 2026 ))/Total Assets (A: Apr. 2025 )
=(3703.86-747.27)/3738.89
=0.79

where

Operating Assets(A: Apr. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3958.65 - 254.79
=3703.86

Operating Liabilities(A: Apr. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=871.245 - 0 - 123.975
=747.27

Minimed Group's Scaled Net Operating Assets (SNOA) for the quarter that ended in Apr. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Apr. 2026 )
=(Operating Assets (Q: Apr. 2026 )-Operating Liabilities (Q: Apr. 2026 ))/Total Assets (Q: Jan. 2026 )
=(3703.86-747.27)/3695.893
=0.80

where

Operating Assets(Q: Apr. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3958.65 - 254.79
=3703.86

Operating Liabilities(Q: Apr. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=871.245 - 0 - 123.975
=747.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.80 mean?
Minimed Group (STU:B8S) has a Scaled Net Operating Assets of 0.80 as of Apr. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Minimed Group and its competitors.
Is Minimed Group's Scaled Net Operating Assets too high?
Minimed Group's current Scaled Net Operating Assets is 0.80. Overall, Minimed Group has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's Scaled Net Operating Assets compare to MMSI and NVST?
Minimed Group's Scaled Net Operating Assets of 0.80 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Minimed Group and its competitors. Minimed Group's current Scaled Net Operating Assets is 0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (STU:B8S) has a current Scaled Net Operating Assets of 0.80. The current Scaled Net Operating Assets is 0.80. Minimed Group's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Minimed Group (STU:B8S), the current Scaled Net Operating Assets is 0.80 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minimed Group Business Description

Other Exchanges MMED:USA
Address 18000 Devonshire Street, Northridge, CA, USA, 91325
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
20GF Score

Get the complete analysis for STU:B8S

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.60
Price